Patents by Inventor Dale Edward Shuster

Dale Edward Shuster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220034871
    Abstract: The present disclosure relates generally to methods for using pexidartinib and related Risk Evaluation and Mitigation Strategy (REMS), while reducing the occurrence of hepatotoxic adverse events.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 3, 2022
    Inventors: Dale Edward SHUSTER, Hamim ZAHIR, Ophelia Qiping YIN, Leonidas Daniel DROGARIS, Vikram Jeet DEV, Laurie DELEVE, James Hendricks LEWIS
  • Publication number: 20220036993
    Abstract: The present disclosure relates generally to methods for using pexidartinib and related Risk Evaluation and Mitigation Strategy (REMS), while reducing the occurrence of hepatotoxic adverse events.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 3, 2022
    Inventors: Dale Edward SHUSTER, Hamim ZAHIR, Ophelia Qiping YIN, Leonidas Daniel DROGARIS, Vikram Jeet DEV, Laurie DELEVE, James Hendricks LEWIS
  • Patent number: 8119667
    Abstract: Novel fenicol compounds having useful properties as antibiotic prodrugs, are provided, together with methods of making and using these new compounds.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: February 21, 2012
    Assignee: Schering-Plough Animal Health Corporation
    Inventors: Tomasz W. Glinka, Dale Edward Shuster, Chander Shekher Celly, Robert D. Simmons, Jason Zhang
  • Publication number: 20070155799
    Abstract: Novel fenicol compounds having useful properties as antibiotic prodrugs, are provided, together with methods of making and using these new compounds.
    Type: Application
    Filed: December 18, 2006
    Publication date: July 5, 2007
    Inventors: Tomasz W. Glinka, Dale Edward Shuster, Chander Shekher Celly, Robert D. Simmons, Jason Zhang